Physician profile
Grishma Joy
NPI 1336239656
$1,743.24
in general payments reported to CMS, 2019-2025
18 companies · $506 in 2025
The $506 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $62.72 · 2021: $146 · 2022: $125 · 2023: $163 · 2024: $559 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $686.50 | 2021-2025 | |
| Pfizer INC. | $256.29 | 2019-2025 | |
| Janssen Biotech, INC. | $212.04 | 2019-2025 | Stelara, Tremfya |
| Celgene Corporation | $116.12 | 2021-2024 | Zeposia |
| Daiichi Sankyo INC. | $88.36 | 2024-2025 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $70.77 | 2025 | Eohilia, Entyvio |
| Qol Medical, LLC | $64.58 | 2019-2020 | |
| Madrigal Pharmaceuticals | $45.88 | 2024-2025 | Resmetirom, Rezdiffra |
| Romark Laboratories, Lc | $31.85 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.69 | 2019-2022 | |
| Novo Nordisk INC | $23.14 | 2025 | Wegovy |
| Micro-Tech Endoscopy USA, INC. | $21.52 | 2024 | Lockado |
| Ardelyx, INC. | $21.52 | 2024 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $16.63 | 2022 | |
| Shire North American Group INC | $15.92 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $14.65 | 2024 | |
| Allergan, INC. | $13.82 | 2019 | |
| Meridian Bioscience INC. | $11.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grishma Joy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.